Symphonytech Biologics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-12-2024
- Paid Up Capital ₹ 0.10 M
as on 28-12-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit -102.69%
(FY 2020)
- Ebitda -102.69%
(FY 2020)
- Net Worth 134.85%
(FY 2020)
- Total Assets 6258.09%
(FY 2020)
About Symphonytech Biologics
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ravindra Khare, Atul Khandekar, and Narendra Chirmule serve as directors at the Company.
- CIN/LLPIN
U74999PN2018PTC178726
- Company No.
178726
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Symphonytech Biologics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Khare  | Director | 14-Sep-2018 | Current |
| Atul Khandekar | Director | 14-Sep-2018 | Current |
Narendra Chirmule  | Director | 11-May-2019 | Current |
Financial Performance of Symphonytech Biologics.
Symphonytech Biologics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 102.69% decrease in profit. The company's net worth Soared by an impressive increase of 134.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Symphonytech Biologics?
Unlock access to Symphonytech Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Symphony Technologies Private LimitedActive 25 years 7 monthsRavindra Khare, Atul Khandekar and 1 more are mutual person
Symphonytech Centre For Social Science Research LlpActive 1 year 11 monthsRavindra Khare is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Symphonytech Biologics?
Unlock and access historical data on people associated with Symphonytech Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Symphonytech Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symphonytech Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
